Harvard Business Review

JUNE 9, 2017

Legitimate concerns over conflict of interest that have resulted in overly extreme preventative policies are a central cause. It is time for all parties to revisit those policies and replace them with rules that recognize both true conflicts and true confluences of interest. Insight Center. Sponsored by Optum.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

SEPTEMBER 19, 2016

From a historical perspective, the idea that managers in organizations have a single, dominant duty — to achieve or maximize economic returns — is a striking development. In addition, 30 states have passed laws that explicitly authorize companies to consider the interests of parties other than shareholders.

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

DECEMBER 6, 2012

For example, the SEC in 2010 had charged Goldman with misleading some of the parties to a billion dollar transaction (involving a complex derivative called a synthetic collateralized debt obligation), alleging specific facts about undisclosed conflicts of interest. Goldman settled within months for $550 million.

Conflict of Interest 8

Conflict of Interest CEO Asset Management Committee 8